Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

TQB3702 Tablets

TQB3702 is a selective kinase inhibitor.

DRUG

TQB3702 Tablets+TQB3702 Placebo

TQB3702 is a selective kinase inhibitor; A placebo is a simulated drug whose physical properties, such as appearance, size, color, dosage form, weight, taste, and odor are substantially the same as the test drug, but cannot contain the active ingredients of the test drug.

DRUG

TQB3702 Placebo

TQB3702 Placebo without drug substance.

Trial Locations (37)

41000

Xiangya Third Hospital of Central South University, Changsha

65000

Hebei petro China central hospital, Langfang

100191

Peking University Third Hospital, Beijing

110000

Shenjing Hospital of China Medical University, Shenyang

The First Affiliated Hospital of China Medical University, Shenyang

130021

The First Hospital of Jilin University, Changchun

135000

Meihekou Central Hospital, Meihekou

200001

Shanghai Jiao Tong University School of Medicine,Renji Hospital, Shanghai

200433

Changhai Hospital of Shanghai, Shanghai

210000

Jiangsu Provincial People's Hospital, Nanjing

215006

The First Affiliated Hospital of Soochow University, Suzhou

230001

Anhui Provincial Hospital, Hefei

233000

The First Affilliated Hospital of Bengbu Medical University, Bengbu

250011

Affiliated hospital of Shandong Academy of Medical Sciences, Jinan

300190

Tianjin First Central Hospital, Tianjin

318001

Taizhou Central Hospital(Taizhou University Hospital), Taizhou

325027

The 1th School of Medicine,School of Information and Engineering,The 1th Affiliated Hospital of WMU, Wenzhou

325200

Wenzhou People's Hospital, Wenzhou

330006

The First Affiliated Hospital of Nanchang University, Nanchang

422000

Shaoyang Central Hospital, Shaoyang

430000

Huazhong University of Science and Technology Tongji Medical College of Huazhong University of Science and Technology, Wuhan

450000

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

457001

Puyang Oilfield General Hospital, Puyang

510000

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

518035

Shenzhen second people's hospital, Shenzhen

530021

The First Affiliated Hospital of Guangxi Medical University, Nanning

610000

Chengdu Second People's Hospital, Chengdu

621099

Mianyang central hispital, Mianyang

650034

Third People's Hospital of Yunnan Province, Kunming

665099

Pu'er People's Hospital, Pu'er

710000

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

The First Hospital Affiliated to the Army Medical University, Xi'an

730030

The People's Hospital of Gansu Province, Lanzhou

05000

The second hospital of hebei medical university, Shijiazhuang

Unknown

Shiyan People's Hospital, Shiyan

030000

Shanxi Bethune Hospital, Taiyuan

030001

First Hospital of Shangxi Medical University, Taiyuan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY